|
H6: code c19: a review of manufacturing records verified that the lots involved in this complaint met all pre-release specifications.H6: code b20: device remains implanted and therefore not available for direct analysis.H6: code d12: according to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: endoleak.As gore was unable to determine which component was involved in this event the following gore® excluder® aaa endoprosthesis devices will be added to this report: 1.Catalogue: pxc121400 serial: (b)(6).Udi: (b)(4).2.Catalogue: pxl161207 serial: (b)(6).Udi: (b)(4).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
The following information was reported to gore: on (b)(6) 2010, this patient underwent endovascular treatment using gore® excluder® aaa endoprosthesis for an abdominal aortic aneurysm.On an unknown date, regular follow-up revealed common iliac artery dilatation and distal type i endoleak.Of the 3 devices that were implanted during initial procedure it is unknown which one was related to the distal type i endoleak.On (b)(6) 2023, the patient underwent reintervention.Reportedly, an additional stent graft was placed.
|